FDA Adverse Event Injury Summary report: N

12/14 ARTICUL 40MM M SPEC+12

MDR report key: 3130548 · Received May 24, 2013

Report

Report Number
1818910-2013-17658
Event Type
Injury
Date Received
May 24, 2013
Date of Event
May 7, 2013
Report Date
June 13, 2013
Manufacturer
DEPUY ORTHOPAEDICS INC US
Product Code
JDI
PMA / PMN Number
K060031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. PATIENT WAS REVISED TO ADDRESS FLUID POCKETS ON MDR WHICH TURNED OUT TO BE CYSTIC PSEUDO TUMORS. PATIENT ALSO COMPLAINED OF PAINFUL ARTICULATION. DOI (B)(6) 2007 - DOR (B)(6) 2013 (RIGHT HIP). UPDATE 06/13/2013 - PATIENT'S MEDICAL RECORDS WERE RECEIVED. RECORDS INDICATE THE PATIENT WAS REVISED TO ADDRESS OSTEOLYSIS AND PAIN. UPON REVISION BROWN FLUID FILLED MASSES WERE FOUND IN THE HIP ALONG WITH CORROSION AROUND THE MORES TAPER. THE STEM IS BEING ADDED TO THE COMPLAINT. THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS FOR THE PROVIDED PRODUCT/LOT COMBINATIONS DID NOT REVEAL ANY RELATED MANUFACTURING DEVIATIONS OR ANOMALIES. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE FOR THE STEM AS THE PRODUCT AND LOT CODE REQUIRED WAS NOT PROVIDED. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. MEDICAL RECORDS WERE OBTAINED AND REVIEWED. FROM A MEDICAL PERSPECTIVE, BASED ON THE INFORMATION AVAILABLE, THE COMPLAINTS OF PAIN ARE NOT PRODUCT RELATED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Additional Manufacturer Narrative · 1

UPDATE REC'D 5/12/2014 - LITIGATION PAPERS RECEIVED. IN ADDITION TO WHAT WAS PREVIOUSLY REPORTED, LITIGATION ALLEGES THE PATIENT SUFFERS FROM METAL IONS, AND DIFFICULTY AMBULATING.DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

NO DEVICE ASSOCIATED WITH THIS REPORT WAS RECEIVED FOR EXAMINATION. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

UDI: (B)(4).

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS FLUID POCKETS ON MDR WHICH TURNED OUT TO BE CYSTIC PSEUDOTUMORS. PATIENT ALSO COMPLAINED OF PAINFUL ARTICULATION.

Description of Event or Problem · 1

AFTER REVIEW OF MEDICAL RECORDS FOR MDR REPORTABILITY IT WAS ALSO REPORTED THAT THE PATIENT'S RIGHT LEG WAS SHORT BY ABOUT 2 TO 3 MM.

Description of Event or Problem · 1

PPF ALLEGES METALLOSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
231086 12/14 ARTICUL 40MM M SPEC+12 HIP FEMORAL HEAD JDI DEPUY ORTHOPAEDICS INC US 2407746

Patients

Seq Age Sex Outcome Treatment
1 79 YR Required Intervention